Octagon Capital Advisors LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$740.1M2026 Q3+ $10.6M options (notional, not included)
Positions26
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.82.5%

Octagon Capital Advisors LP reported 26 positions worth $740.1M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: DNTH (19.8%). Biggest move: reduce GOSS ($90.7M).

10 / 26 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 DNTHDianthus Therapeutics$148.5M19.79%1,686,667——+1.7%
▸ 2 ABVXAbivax S.A.$98.3M13.10%993,000———
▸ 3 DFTXDefinium Therapeutics$95.6M12.73%2,511,000——-20.8%
▸ 4 COGTCogent Biosciences$75.2M10.02%2,350,000——-10.8%
▸ 5 AVBPArriVent BioPharma$64.8M8.64%2,141,387——-57.0%
▸ 6 TSHATaysha Gene Therapies$47.2M6.29%9,693,244——-16.6%
▸ 7 OBXObsidian Therapeutics$33.2M4.42%2,414,610———
▸ 8 KYMRKymera Therapeutics$22.9M3.05%205,000——+14.1%
▸ 9 IRONDisc Medicine$17.7M2.35%270,000——+17.0%
▸ 10 TNGXTango Therapeutics$15.7M2.09%630,000——-3.1%

Pro Feature

The remaining 16 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Octagon Capital Advisors LP hold as of Q3 2026?

Octagon Capital Advisors LP reported 26 positions worth $740.1M in its Q3 2026 13F filing. Largest positions: DNTH (19.8%), ABVX (13.1%), DFTX (12.7%), COGT (10.0%) and AVBP (8.6%).

What did Octagon Capital Advisors LP buy in Q3 2026?

New positions: OBX and TNGX. Added to: AVBP.

What did Octagon Capital Advisors LP sell in Q3 2026?

Reduced: GOSS, DFTX, MIRM, DNTH and KYMR (14 in all). Sold out entirely: ALMS, SMMT and CONTEXT THERAPEUTICS INC.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.